114 related articles for article (PubMed ID: 839976)
21. Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.
Lang CC; Rahman AR; Struthers AD
Br J Clin Pharmacol; 1991 Jul; 32(1):51-6. PubMed ID: 1832287
[TBL] [Abstract][Full Text] [Related]
22. The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects.
Jungmann E; Althoff PH; Hermann GJ; Schöffling K
Arzneimittelforschung; 1984; 34(9):1022-4. PubMed ID: 6391497
[TBL] [Abstract][Full Text] [Related]
23. Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat.
Sowers JR; Sollars EG; Tuck ML; Asp ND
Proc Soc Exp Biol Med; 1980 Sep; 164(4):598-603. PubMed ID: 6997889
[No Abstract] [Full Text] [Related]
24. Dopamine control of aldosterone secretion in end-stage renal failure.
García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
[TBL] [Abstract][Full Text] [Related]
25. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
[TBL] [Abstract][Full Text] [Related]
26. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
[TBL] [Abstract][Full Text] [Related]
27. Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis.
Bernardi M; De Palma R; Trevisani F; Malatesta R; Baraldini M; Cursaro C; Gasbarrini G
Clin Sci (Lond); 1988 Feb; 74(2):137-43. PubMed ID: 3338258
[TBL] [Abstract][Full Text] [Related]
28. Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide.
Degli Uberti EC; Trasforini G; Margutti AR; Rotola CA; Bianconi M; Pansini P
Horm Res; 1983; 17(3):160-7. PubMed ID: 6343215
[TBL] [Abstract][Full Text] [Related]
29. Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
Krishna GG; Chusid P; Hoeldtke RD
Nephron; 1987; 47(3):184-9. PubMed ID: 3683686
[TBL] [Abstract][Full Text] [Related]
30. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
[TBL] [Abstract][Full Text] [Related]
31. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
Sowers JR; Sharp B; McCallum RW
J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic control of serum potassium.
Bevilacqua M; Norbiato G; Raggi U; Micossi P; Baggio E; Prandelli M
Metabolism; 1980 Apr; 29(4):306-10. PubMed ID: 6990171
[TBL] [Abstract][Full Text] [Related]
33. Effect of ganglionic blockade with trimethaphan on corticosteroid responses to metoclopramide in rhesus monkeys.
Sowers JR; Beck FW; Eggena P
J Hypertens; 1984 Aug; 2(4):367-70. PubMed ID: 6152278
[TBL] [Abstract][Full Text] [Related]
34. Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
Beck FW; Sowers JR; Sicca D; Welch BG
Life Sci; 1985 Jun; 36(25):2435-44. PubMed ID: 2989637
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldosterone response to metoclopramide in man.
Sowers JR; Beck FW; Stern N
Life Sci; 1983 Dec; 33(25):2489-95. PubMed ID: 6645810
[TBL] [Abstract][Full Text] [Related]
36. Effect of metoclopramide on the secretion and metabolism of aldosterone in man.
Brown RD; Wisgerhof M; Jiang NS; Kao P; Hegstad R
J Clin Endocrinol Metab; 1981 May; 52(5):1014-8. PubMed ID: 7228985
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a role of a serum factor stimulated by metoclopramide in regulating aldosterone secretion.
Bevilacqua M; Scorza D; Meroni R; Vago T; Dagani R; Malacco E; Norbiato G
Biochem Biophys Res Commun; 1984 Feb; 119(1):95-100. PubMed ID: 6704135
[TBL] [Abstract][Full Text] [Related]
38. Effect of L-dopa and bilateral nephrectomy on the aldosterone response to metoclopramide.
Sowers JR; Sollars E; Barrett JD; Sambhi MP
Life Sci; 1980 Aug; 27(6):497-501. PubMed ID: 6997667
[No Abstract] [Full Text] [Related]
39. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
[TBL] [Abstract][Full Text] [Related]
40. Effect of fenoldopam on the aldosterone response to metoclopramide in man.
Dupont AG; Vanderniepen P; Volckaert A; Smitz J; Vansteirteghem AC; Six RO
Clin Endocrinol (Oxf); 1986 Feb; 24(2):203-8. PubMed ID: 2871951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
